Atlas Trials

A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.

Clinical trial NCT06321510 · COMPLETED

Trial details

NCT number
NCT06321510
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Lung Cancer
Start date
2024-07-01
Primary completion
2025-09-19
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.